Macrolane, an injectable filler used for "lunchtime boob jobs", is to be withdrawn for such purposes this week.
A survey by the British Association of Aesthetic Plastic Surgeons (BAAPS) found that 25% of its members noticed patient complications from the filler.
Experts warn it could effect breast cancer screenings but manufacturer Q-Med said there was a lack of consensus.
The Medicines and Healthcare products Regulatory Agency (MHRA) said Macrolane could effect mammogram readings and make diagnosis more difficult.
A spokesman said there were no safety concerns with the product itself, and it could still be used for other purposes such as "augmenting body contour" and correcting soft tissue defects.
Source: BBC
No comments:
Post a Comment